Plus Therapeutics to rebrand as Cerenome, trade as CNSY on Aug. 3
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
June 30, 2026 7:30 AM EDTPlus Therapeutics to become Cerenome, to trade under new Nasdaq ticker CNSY on August 3, 2026
Affirms 2026 guidance on key milestones
Reports positive CNSide® commercial progress
HOUSTON, June 30, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (Plus or the Company), a healthcare company focused on central nervous system (CNS) cancers, today provides a comprehensive business update. Notably, the Company announces it is changing its company name from Plus Therapeutics to Cerenome and Nasdaq ticker to CNSY, effective August 3, 2026. Furthermore, the Company affirmed its... More
